COMPARISON OF MEDICATION ADHERENCE TO INTERFERON BETA-1B AND INTERFERON BETA-1A SUBCUTANEOUS IN MULTIPLE SCLEROSIS PATIENTS

被引：0

作者：

Meletiche, D. M. ^{[1
]}

Kozma, C. ^{[2
]}

Dickson, M. ^{[3
]}

机构：

[1] EMD Serono Inc, Rockland, MA USA

[2] Univ S Carolina, W Columbia, SC USA

[3] Univ S Carolina, Columbia, SC 29208 USA

来源：

VALUE IN HEALTH | 2009年 / 12卷 / 03期

关键词：

D O I：

10.1016/S1098-3015(10)74029-8

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A194 / A194

页数：1

共 50 条

[1] Interferon beta-1a and beta-1b for treatment of multiple sclerosis - Reply
Durelli, L
[J]. LANCET, 2002, 360 (9343): : 1428 - 1429
[2] COST-UTILITY ANA LYSIS OF INTRAMUSCULAR INTERFERON BETA-1B VERSUS SUBCUTANEOUS INTERFERON BETA-1B AND BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN COLOMBIA
Ordonez, J.
Delgado, A.
[J]. VALUE IN HEALTH, 2016, 19 (03) : A63 - A63
[3] Comparison of interferon β-1a subcutaneous and interferon β-1b on medication adherence in patients with multiple sclerosis
Joyeux, A.
Meletiche, D.
Kozma, C.
Dickson, M.
Bennett, R.
[J]. JOURNAL OF NEUROLOGY, 2009, 256 : S162 - S163
[4] IMPACT OF ADHERENCE ON SUBCUTANEOUS INTERFERON BETA-1A EFFECTIVENESS ADMINISTERED BY REBISMART® IN PATIENTS WITH MULTIPLE SCLEROSIS
Edo-Solsona, M.
Monte-Boquet, E.
Casanova-Estruch, B.
Poveda-Andres, J.
[J]. VALUE IN HEALTH, 2016, 19 (07) : A435 - A435
[5] Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart® in patients with multiple sclerosis
Edo Solsona, Maria Dolores
Monte Boquet, Emilio
Casanova Estruch, Bonaventura
Poveda Andres, Jose Luis
[J]. PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 415 - 421
[6] Health economic evaluation of interferon beta-1a versus interferon beta-1b for patients with relapsing-remitting multiple sclerosis in Switzerland
Nuijten, M. J. C.
Chofflon, M.
[J]. MULTIPLE SCLEROSIS, 2007, 13 : S262 - S262
[7] Interferon beta-1b and childhood multiple sclerosis
Adams, AB
Tyor, WR
Holden, KR
[J]. PEDIATRIC NEUROLOGY, 1999, 21 (01) : 481 - 483
[8] Treatment of multiple sclerosis with interferon beta-1b
AbdulAhad, A
Shah, S
Galazka, A
[J]. NEUROLOGY, 1997, 49 (02) : 641 - 641
[9] Interferon Beta-1b (Extavia) for Multiple Sclerosis
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1350): : 86 - 87
[10] Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration
Khan, OA
Xia, Q
Bever, CT
Johnson, KP
Panitch, HS
DhibJalbut, SS
[J]. NEUROLOGY, 1996, 46 (06) : 1639 - 1643

← 1 2 3 4 5 →